Literature DB >> 11750792

Regulation of 5-HT(1A) and 5-HT(1B) receptor systems by phospholipid signaling cascades.

K A Berg1, W P Clarke.   

Abstract

The 5-HT(1A) and 5-HT(1B) receptor systems play central roles in the control of serotonergic neurotransmission and feature prominently in many behaviors and physiological functions. In addition, the regulation of these receptors and their effector mechanisms has been the focus of intense interest because of their potential importance in the therapeutic actions of anxiolytic and antidepressant drugs. Here we describe the regulation of 5-HT(1A) and 5-HT(1B) receptor-mediated inhibition of adenylyl cyclase activity by receptors which activate phospholipid signaling cascades. Although it might be expected that these two highly homologous Gi-coupled receptors would be regulated similarly by activation of phospholipase C (PLC) and phospholipase A(2) (PLA(2)), we have found that the regulation differs markedly between these receptor systems. Further, our data suggest that the modulation of agonist efficacy at these receptor subtypes is dependent on the nature of receptor coupling to PLC and PLA(2) activation. Moreover, regulation at the level of the effector (e.g., adenylyl cyclase) appears to play a significant role in the regulation of both the 5-HT(1A) and 5-HT(1B) receptor systems by the PLA(2) signaling cascade. Such data illustrate multiple levels for control of biochemical signaling cascades within cells and demonstrate that although different receptors may couple to the same effector pathways, the ultimate cellular effects produced by these receptors may differ due to differential cross-talk regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750792     DOI: 10.1016/s0361-9230(01)00645-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  5-HT1B Receptor-Mediated Activation of ERK1/2 Requires Both Gαi/o and β-Arrestin Proteins.

Authors:  Yusha Liu; Alec W Gibson; Marjorie R Levinstein; Atom J Lesiak; Shao-En Ong; John F Neumaier
Journal:  ACS Chem Neurosci       Date:  2019-04-29       Impact factor: 4.418

2.  Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass.

Authors:  Michael P Robich; Eugenio G Araujo; Jun Feng; Robert M Osipov; Richard T Clements; Cesario Bianchi; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07-25       Impact factor: 5.209

3.  Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.

Authors:  R Vidal; E M Valdizan; M T Vilaró; A Pazos; E Castro
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Decreased contractile response of peripheral arterioles to serotonin after CPB in patients with diabetes.

Authors:  Sharif A Sabe; Jun Feng; Yuhong Liu; Laura A Scrimgeour; Afshin Ehsan; Frank W Sellke
Journal:  Surgery       Date:  2018-08       Impact factor: 3.982

5.  The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.

Authors:  Julia Bräunig; Juliane Dinter; Carolin S Höfig; Sarah Paisdzior; Michal Szczepek; Patrick Scheerer; Mark Rosowski; Jens Mittag; Gunnar Kleinau; Heike Biebermann
Journal:  Front Pharmacol       Date:  2018-03-12       Impact factor: 5.810

6.  The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse.

Authors:  Dubravka Svob Strac; Gordana Nedic Erjavec; Matea Nikolac Perkovic; Korona Nenadic-Sviglin; Marcela Konjevod; Mirko Grubor; Nela Pivac
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-24       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.